Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Schäfer, Juliane; Young, Jim; Calmy, Alexandra; Nicca, Dunja; Hasse, Barbara; Brun Del Re, Claudia; Cavassini, Matthias; Bernasconi, Enos; Schmidt-Trucksäss, Arno; Bucher, Heiner C; Swiss HIV Cohort Study (2017). High prevalence of physical inactivity among patients from the Swiss HIV cohort study. AIDS Care, 29(8):1056-1061.

Shilaih, Mohaned; Marzel, Alex; Braun, Dominique L; Scherrer, Alexandra U; Kovari, Helen; Young, Jim; Calmy, Alexandra; Darling, Katharine; Battegay, Manuel; Hoffmann, Matthias; Bernasconi, Enos; Thurnheer, Maria C; Günthard, Huldrych F; Kouyos, Roger D; Swiss HIV Cohort Study (2017). Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine, 96(2):e5849.

Prague, Mélanie; Commenges, Daniel; Gran, Jon Michael; Ledergerber, Bruno; Young, Jim; Furrer, Hansjakob; Thiébaut, Rodolphe (2017). Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study. Biometrics, 73(1):294-304.

Young, Jim; Moodie, Erica E M; Abrahamowicz, Michal; Klein, Marina B; Weber, Rainer; Bucher, Heiner C (2015). Incomplete modeling of the effect of antiretroviral therapy on the risk of cardiovascular events. Clinical Infectious Diseases, 61(7):1206-1207.

Young, Jim; Xiao, Yongling; Moodie, Erica E M; Abrahamowicz, Michal; Klein, Marina B; Bernasconi, Enos; Schmid, Patrick; Calmy, Alexandra; Cavassini, Matthias; Cusini, Alexia; Weber, Rainer; Bucher, Heiner C (2015). Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 69(4):413-421.

Young, Jim; Rickenbach, Martin; Calmy, Alexandra; Bernasconi, Enos; Staehelin, Cornelia; Schmid, Patrick; Cavassini, Matthias; Battegay, Manuel; Günthard, Huldrych F; Bucher, Heiner C (2015). Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study. BMC Infectious Diseases, 15(382):online.

Klein, Marina B; Young, Jim; Dunn, David; Ledergerber, Bruno; Sabin, Caroline; Cozzi-Lepri, Alessandro; Dabis, Francois; Harrigan, Richard; Tan, Darrell H; Walmsley, Sharon; Gill, John; Cooper, Curtis; Scherrer, Alexandra U; Mocroft, Amanda; Hogg, Robert S; Smaill, Fiona (2014). The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: A Canadian-European collaborative retrospective cohort study. CMAJ Open, 2(4):E318-E329.

Wang, Qing; Young, Jim; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Fehr, Jan; Bucher, Heiner C; Battegay, Manuel (2014). Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV Clinical Trials, 15(3):92-103.

Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; Vernazza, Pietro; Hirschel, Bernard; Weber, Rainer; Furrer, Hansjakob; Stoeckle, Marcel; Bucher, Heiner C; Fux, Christoph (2013). The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antiviral Therapy, 18(3):337-344.

Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C (2012). Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS, 26(5):567-575.

This list was generated on Sun Sep 22 07:18:35 2019 CEST.